|
KHSRP expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.92539999996655E-06 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.73749999999551E-05 |
| Normal-vs-Stage2 |
1.237740E-04 |
| Normal-vs-Stage3 |
5.83849999999941E-05 |
| Normal-vs-Stage4 |
3.775400E-04 |
| Stage1-vs-Stage2 |
1.837230E-01 |
| Stage1-vs-Stage3 |
5.383200E-01 |
| Stage1-vs-Stage4 |
8.964400E-01 |
| Stage2-vs-Stage3 |
4.131600E-01 |
| Stage2-vs-Stage4 |
2.887200E-01 |
| Stage3-vs-Stage4 |
6.855400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.19750000000274E-05 |
| Normal-vs-AfricanAmerican |
1.742820E-01 |
| Normal-vs-Asian |
4.216200E-03 |
| Caucasian-vs-AfricanAmerican |
1.780560E-01 |
| Caucasian-vs-Asian |
7.544600E-01 |
| AfricanAmerican-vs-Asian |
3.275200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.50149999999361E-05 |
| Normal-vs-Female |
2.10880000000024E-05 |
| Male-vs-Female |
8.918400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.214000E-04 |
| Normal-vs-Age(41-60Yrs) |
2.71450000000062E-06 |
| Normal-vs-Age(61-80Yrs) |
4.03410000000548E-05 |
| Normal-vs-Age(81-100Yrs) |
7.001600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.490780E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.877200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.285400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.767600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.043000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.458800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.023600E-01 |
| Classical-VS-Follicular |
1.53540002933994E-09 |
| Classical-VS-Other |
2.044600E-01 |
| Classical-VS-Normal |
2.717100E-03 |
| Tall-VS-Follicular |
1.044150E-02 |
| Tall-VS-Other |
4.738000E-01 |
| Tall-VS-Normal |
5.682100E-03 |
| Follicular-VS-Other |
4.936000E-01 |
| Follicular-VS-Normal |
1.02980002303354E-09 |
| Other-VS-Normal |
3.482100E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.64489999996154E-06 |
| Normal-vs-N1 |
1.417760E-03 |
| N0-vs-N1 |
3.091600E-01 |
|
|
